AMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin mice
- 21 February 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (9), 3410-3415
- https://doi.org/10.1073/pnas.0507313103
Abstract
It is widely thought that Alzheimer's disease (AD) begins as a malfunction of synapses, eventually leading to cognitive impairment and dementia. Homeostatic synaptic scaling is a mechanism that could be crucial at the onset of AD but has not been examined experimentally. In this process, the synaptic strength of a neuron is modified so that the overall excitability of the cell is maintained. Here, we investigate whether synaptic scaling mediated by l-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) contributes to pathology in double knockin (2 x KI) mice carrying human mutations in the genes for amyloid precursor protein and presenilin-1. By using whole-cell recordings, we show that 2 x KI mice exhibit age-related downscaling of AMPAR-mediated evoked currents and spontaneous, miniature currents. Electron microscopic analysis further corroborates the synaptic AMPAR decrease. Additionally, 2 x KI mice show age-related deficits in bidirectional plasticity (long-term potentiation and long-term depression) and memory flexibility. These results suggest that AMPARs are important synaptic targets for AD and provide evidence that cognitive impairment may involve downscaling of postsynaptic AMPAR function.Keywords
This publication has 52 references indexed in Scilit:
- Stability of the distribution of spines containing drebrin A in the sensory cortex layer I of mice expressing mutated APP and PS1 genesBrain Research, 2005
- Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?Trends in Neurosciences, 2004
- Homeostatic plasticity in the developing nervous systemNature Reviews Neuroscience, 2004
- Memory enhancement: the search for mechanism-based drugsNature Neuroscience, 2002
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer’s disease☆Neurobiology of Aging, 1999
- Synaptic coexistence of AMPA and NMDA receptors in the rat hippocampus: A postembedding immunogold studyJournal of Neuroscience Research, 1998
- Neuronal-Based Synaptic Compensation: A Computational Study in Alzheimer's DiseaseNeural Computation, 1996
- Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: a biochemical studyBrain Research, 1995